Lars Mjornstedt

Goeteborg, O, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function.

An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function.

Journal: Frontiers in transplantation

Published: February 17, 2026

Attenuation of Torque teno viral load over time in kidney transplantation recipients treated with calcineurin inhibitors is mitigated after conversion to belatacept.

Attenuation of Torque teno viral load over time in kidney transplantation recipients treated with calcineurin inhibitors is mitigated after conversion to belatacept.

Journal: Journal of medical virology

Published: June 12, 2024

Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study).

Tocilizumab in chronic active antibody-mediated rejection: rationale and protocol of an in-progress randomized controlled open-label multi-center trial (INTERCEPT study).

Journal: Trials

Published: December 05, 2023

Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy.

Difficult-to-Treat Rejections in Kidney Transplant Recipients: Our Experience with Everolimus-Based Quadruple Maintenance Therapy.

Journal: Journal of clinical medicine

Published: October 04, 2023

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial.

Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial.

Journal: Kidney medicine

Published: January 03, 2023

The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours.

The risk of graft loss 5 years after kidney transplantation is increased if cold ischemia time exceeds 14 hours.

Journal: Clinical transplantation

Published: March 09, 2018

Oral and lip cancer in solid organ transplant patients--a cohort study from a Swedish Transplant Centre.

Oral and lip cancer in solid organ transplant patients--a cohort study from a Swedish Transplant Centre.

Journal: Oral oncology

Published: August 22, 2014

Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation.

Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: March 19, 2014

An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation.

An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation.

Journal: Transplantation research

Published: March 11, 2014

Successful treatment of severe ABO antibody-mediated rejection using bortezomib: a case report.

Successful treatment of severe ABO antibody-mediated rejection using bortezomib: a case report.

Journal: Transplantation proceedings

Published: April 30, 2013

A randomized, double-blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up.

A randomized, double-blind, placebo-controlled study of single dose rituximab as induction in renal transplantation: a 3-year follow-up.

Journal: Transplantation

Published: August 09, 2012

Improved renal function after early conversion from a calcineurin inhibitor to everolimus: a randomized trial in kidney transplantation.

Improved renal function after early conversion from a calcineurin inhibitor to everolimus: a randomized trial in kidney transplantation.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: July 21, 2012

Showing 1-12 of 12

Last Updated: 09/26/2026